Supplementary protection
LT - N-4-fenilchinazolin-4-amino dariniai ir giminingi junginiai kaip ERBB I tipo receptoriaus tirozinkinazės slopikliai, skirti hiperproliferacinių ligų gydymui
EN - N4-PHENYL-QUINAZOLINE-4 -AMINE DERIVATIVES AND RELATED COMPOUNDS AS ERBB TYPE I RECEPTOR TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF HYPERPROLIFERATIVE DISEASES
SPC
| (11) |
Number of the document |
C 1971601 |
| (68) |
Number of the document |
1971601
|
| (21) |
Application number for Supplementary Protection Certificate |
PA 2021 516 |
| (22) |
Date of filing the application |
2021-07-20 |
| (41) |
Date of publication of the application |
2021-08-10 |
|
Date of publication of SPC |
2022-10-25 |
| (24) |
Date of coming into effect of SPC |
2026-11-16 |
Applicant
| (71) |
Array Biopharma Inc.,
3200 Walnut Street, Boulder, CO 80301,
US
|
Grantee
| (73) |
Array Biopharma Inc.,
3200 Walnut Street, Boulder, CO 80301,
US
|
Attorney or representative
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
Number, date and code of the country of origin of the first authorization to place the medicinal or plant protection product on the market within regional economic community
| (93) |
EU/1/20/1526, 2021-02-11
|
Calculated date of expiry of the SPC
| (94) |
2031-11-15 |
Name of the product protected by the basic patent
| (95) |
Tukatinibas, pasirinktinai farmaciškai priimtinos druskos arba solvato pavidalu |
